Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Stage III Distal Bile Duct Cancer AJCC v8

National Cancer Institute (NCI)Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Stage III Distal Bile Duct Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 2B
Capecitabine
National Cancer Institute (NCI)
Phase 2B
gsk1120212
National Cancer Institute (NCI)
Phase 2B
Cobimetinib
National Cancer Institute (NCI)
Phase 2CCC
Atezolizumab
National Cancer Institute (NCI)
Phase 2CCC

View all 9 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →